The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023
Abstract
PURPOSE: The purpose of this American Urological Association (AUA) Guideline amendment is to provide a useful reference on the effective evidence-based management of male lower urinary tract symptoms secondary/attributed to BPH (LUTS/BPH). MATERIALS AND METHODS: The Minnesota Evidence Review Team searched Ovid MEDLINE, the Cochrane Library, and the Agency for Healthcare Research and Quality (AHRQ) database to identify studies relevant to the management of BPH. The guideline was updated in 2023 to capture eligible literature published between September 2020 and October 2022. When sufficient evidence existed, the body of evidence was assigned a strength rating of A (high), B (moderate), or C (low) for support of Strong, Moderate, or Conditional Recommendations. In the absence of sufficient evidence, additional information is provided as Clinical Principles and Expert Opinions. RESULTS: The BPH amendment resulted in changes to statements/supporting text on combination therapy, photoselective vaporization of the prostate (PVP), water vapor thermal therapy (WVTT), laser enucleation, and prostate artery embolization (PAE). A new statement on temporary implanted prostatic devices (TIPD) was added. In addition, statements on transurethral needle ablation (TUNA) and transurethral microwave thermotherapy (TUMT) were removed and information regarding these legacy technologies was added to the background section. References and the accompanying treatment algorithms were updated to align with the updated text. CONCLUSION: This guideline seeks to improve clinicians' ability to evaluate and treat patients with BPH/LUTS based on currently available evidence. Future studies will be essential to further support these statements to improve patient care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McConnell, J. D., Roehrborn, C. G., Bautista, O. M., Andriole, G. L., Dixon, C. M., Kusek, J. W., Lepor, H., McVary, K. T., Nyberg, L. M., Clarke, H. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030656 · Cited by 2,043
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study
Coupland, C. A. C., Hill, T., Dening, T., Morriss, R., Moore, M., & Hippisley-Cox, J. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.0677 · Cited by 637
Anticholinergic drugs and risk of dementia: case-control study
Richardson, K., Fox, C., Maidment, I., Steel, N., Loke, Y. K., Arthur, A., Myint, P. K., Grossi, C. M., Mattishent, K., Bennett, K., et al. (2018) · BMJ · doi:10.1136/bmj.k1315 · Cited by 520
RHODES, T., GIRMAN, C. J., JACOBSEN, S. J., ROBERTS, R. O., GUESS, H. A., & LIEBER, M. M. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)61621-5 · Cited by 179
Self management for men with lower urinary tract symptoms: randomised controlled trial
Brown, C. T., Yap, T., Cromwell, D. A., Rixon, L., Steed, L., Mulligan, K., Mundy, A. R., Newman, S. P., van der Meulen, J., & Emberton, M. (2006) · BMJ · doi:10.1136/bmj.39010.551319.ae · Cited by 154
Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride
Nguyen, D., Marchese, M., Cone, E. B., Paciotti, M., Basaria, S. S., Bhojani, N., & Trinh, Q. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.3385 · Cited by 125
Chughtai, B. I., Elterman, D., Shore, N. D., Gittleman, M. C., Motola, J., Pike, S., Hermann, C., Terens, W., KOHAN, A. D., González, R. R., et al. (2020) · Urology · doi:10.1016/j.urology.2020.12.022 · Cited by 97
Fwu, C., Eggers, P. W., Kırkalı, Z., McVary, K. T., Burrows, P. K., & Kusek, J. W. (2013) · The Journal of Urology · doi:10.1016/j.juro.2013.12.014 · Cited by 78
SUFU white paper on overactive bladder anticholinergic medications and dementia risk
Zillioux, J. M., Welk, B. K., Suskind, A. M., Gormley, E. A., & Goldman, H. B. (2022) · Neurourology and Urodynamics · doi:10.1002/nau.25037 · Cited by 65
Elterman, D., Alshak, M. N., Díaz, S. M., Shore, N. D., Gittleman, M. C., Motola, J., Pike, S., Hermann, C., Terens, W., KOHAN, A. D., et al. (2022) · Journal of Endourology · doi:10.1089/end.2022.0226 · Cited by 21
Metadata
- Authors
- Sandhu, J. S., Bixler, B. R., Dahm, P., Goueli, R., Kirkby, E., Stoffel, J. T., & Wilt, T. J.
- Venue
- Journal of Urology
- Published
- 2024-01
- Volume
- 211
- Issue
- 1
- Pages
- 11-19
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W4386725477
- Cited by
- 503
- References
- 11
- FWCI
- 131.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023. https://app.cochat.ai/papers/10.1097/ju.0000000000003698
- The paper
- Sandhu, J. S., Bixler, B. R., Dahm, P., Goueli, R., Kirkby, E., Stoffel, J. T., & Wilt, T. J. (2024). Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023. Journal of Urology. https://doi.org/10.1097/ju.0000000000003698
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.